Clinical Trials Browser

Completed × Glioblastoma × montanide ISA 51 × Clear all

NCT04013672 2024-08-28

Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence

Phase 2 Completed

41 enrolled 15 charts

Glioblastoma